Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $173.31 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $39.28 | 2 | $0 (2024) |
| Horizon Therapeutics plc | $35.33 | 2 | $0 (2023) |
| Lilly USA, LLC | $30.80 | 1 | $0 (2024) |
| Grifols USA, LLC | $22.55 | 1 | $0 (2024) |
| Organon LLC | $16.43 | 1 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $15.54 | 1 | $0 (2023) |
| Genentech USA, Inc. | $13.38 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $73.06 | 3 | Lilly USA, LLC ($30.80) |
| 2023 | $100.25 | 6 | Horizon Therapeutics plc ($35.33) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Immunology and Neurology | ||||||
| 10/02/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: Immunology | ||||||
| 04/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/26/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: TEPEZZA | ||||||
| 05/03/2023 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Genetic Disease | ||||||
| 04/25/2023 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: INFLIXIMAB | ||||||
| 04/19/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: KRYSTEXXA | ||||||
| 04/13/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Immunology | ||||||
About Shantel Valentin, FNP-BC
Shantel Valentin, FNP-BC is a Family healthcare provider based in Elmsford, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2022. The National Provider Identifier (NPI) number assigned to this provider is 1073274874.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shantel Valentin, FNP-BC has received a total of $173.31 in payments from pharmaceutical and medical device companies, with $73.06 received in 2024. These payments were reported across 9 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($173.31).
Practice Information
- Specialty Family
- Location Elmsford, NY
- Active Since 01/04/2022
- Last Updated 01/27/2026
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1073274874
Products in Payments
- XARELTO (Drug) $39.28
- OMVOH (Drug) $30.80
- Gamunex-C (Biological) $22.55
- KRYSTEXXA (Biological) $20.44
- RENFLEXIS (Drug) $16.43
- GIVLAARI (Drug) $15.54
- TEPEZZA (Drug) $14.89
- Xolair (Biological) $13.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.